Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung

Journal of Thoracic Oncology

Volumn 2, Issue 12, 2007, Pages 1098-1102

  Matsuoka, Katsunari ^a   Sumitomo, Shinichi ^b   Misaki, Noriyuki ^b  

^a NATIONAL HOSPITAL ORGANIZATION HIMEJI MEDICAL CENTER   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Lung cancer; Lymph node; Outcome; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

EID: 37349047783     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31815ba227     Document Type: Article

References (16)

1. Marra A, Hillejan L, Zaboura G, et al. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg 2003;125:543-553.
2. Van Velzen E, Snijder RJ, de la Riviere AB, et al. Lymph node type as a prognostic factor for survival in T2N1M0 non-small cell lung carcinoma. Ann Thorac Surg 1997;63:1436-1440.
3. Sayar A, Turna A, Kilicgun A, et al. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. Eur J Cardiothorac Surg 2004;25:434-438.
4. Osaki T, Nagashima A, Yoshimatsu T, et al. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 2004;43:151-157.
5. Yano T, Yokoyama H, Inoue T, et al. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 1994;107:1398-1402.
6. Yoshino I, Nakanishi R, Osaki T, et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastasis. Chest 1999;116:144-149.
7. Van Velzen E, Snijder RJ, de la Riviere AB, et al. Type of lymph node involvement influences survival rates in T1N0M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastasis. Chest 1996;110:1469-1473.
8. Rea F, Marulli G, Callegaro D, et al. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2. Lung Cancer 2004;45:215-220.
9. Ueda K, Kaneda Y, Sakano H, et al. Independent predivtive value of the overall number of metastastic N1 and N2 stations in lung cancer. Jpn J Thorac Cardiovasc Surg 2003;51:297-301.
10. Tanaka F, Yanagihara K, Otake Y, et al. Prognostic factors in patients with resected pathologic (p-)T1-2N1M0 non-small cell lung cancer (NSCLC). Eur J Cardiothorac Surg 2001:19;555-561.
11. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
12. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-839.
13. Ferguson MK, Little AG, Golomb HM, et al. The role of adjuvant therapy after resection of T1N1M0 and T2N1M0 non-small cell lung cancer. J Thorac Cardiovasc Surg 1986;91:344-349.
14. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-447.
15. Riquet M, Manach D, Le Pimpec-Barthes F, et al. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg 1999;67:1572-1576.
16. Ueda K, Kaneda Y, Saeki K, et al. Hilar lymph nodes in N2 disease: survival analysis of patients with non-small-cell lung cancer and regional lymph node metastasis. Surg Today 2002;32:300-304.